Skip to main content
Egyptian Rheumatology and Rehabilitation
Download PDF
  • Original article
  • Open access
  • Published:

Assessment of 25-hydroxyvitamin D level in patients with Behçet’s Disease and its correlation with disease activity and severity

Egyptian Rheumatology and Rehabilitation volume 44, pages 30–38 (2017)Cite this article

Abstract

Objective

The aim of this study was to assess the level of vitamin D in Behçet’s disease (BD) patients and in healthy controls, and to correlate its level with clinical and laboratory data as well as disease activity and severity.

Patients and methods

Forty patients with BD and 40 age-matched and sex-matched healthy controls participated in this study. Serum 25-hydroxyvitamin D [25(OH)D] was estimated using enzyme-linked immunosorbent assay in both patients and controls. Behçet’s Disease Current Activity Form 2006 was used to assess disease activity. Disease severity was evaluated in BD patients.

Results

The mean 25(OH)D level in BD patients was lower than that in the control group, but with no statistical significance (P>0.05). The frequency of vitamin D deficiency was (27.5%)inBDpatientswhereas in controls, itwas (7.5%), andthe frequency of normal vitamin D level in BD was (2.5%) whereas in controls, it was (15%); the difference between the patients and controls was statistically significant (P=0.006). We found a significant negative correlation between the serumvitamin D level in BD patients and disease duration (r=−3.38; P=0.015). No significant correlation was found between the 25(OH)D level and disease activity ofBDpatients (P>0.05). According to the level of vitamin D, we classified our patients into three groups: normal (>30 ng/ml), insufficient (10–30 ng/ml), and deficient (<10 ng/ml) vitamin D level. A statistically significant difference was found between the three groups of BD patients with regard to the serum calcium level (P=0.03) and disease severity (P=0.028).

Conclusion

Vitamin D was lower in BD patients than in the healthy control group; hence, assessment of its level should be carried out in all patients with BD. Furthermore, vitamin D could be used as a new marker for disease severity in BD.

References

  1. Baris N, Okan T, Gurler O, Akdeniz B, Turker S, Ilknur S. Evaluation of left ventricular diastoliic dysfunction with conventional and current Doppler techniques in Behçet’s disease. Clin Rheumatol 2006; 25:873–876.

    Article  Google Scholar 

  2. Gül A. Behçet’s disease: an update on the pathogenesis. Clin Exp Rheumatol 2001; 19:6–12.

    Google Scholar 

  3. Hewison M, Adams JS. Vitamin D insufficiency and skeletal development in utero. J Bone Miner Res 2010; 25:11–13.

    Article  CAS  Google Scholar 

  4. Cianferotti L, Marcocci C. Subclinical vitamin D deficiency. Best Pract Res Clin Endocrinol Metab 2012; 26:523–537.

    Article  CAS  Google Scholar 

  5. Gopinath K, Danda D. Supplementation of 1,25 dihydroxy vitamin D3 in patients with treatment naive early rheumatoid arthritis: a randomised controlled trial. Int J Rheum Dis 2011; 14:332–339.

    Article  Google Scholar 

  6. Karray EF, Ben Abdelghani K, Ben Ghorbel I, Khanfir M, Houman H, Hamzaoui K, et al. Associations of vitamin D receptor gene polymorphisms FokI and BsmI with susceptibility to rheumatoid arthritis and Behçet’s disease in Tunisians. Joint Bone Spine 2012; 79:144–148.

    Article  CAS  Google Scholar 

  7. Kamen DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 2006; 5:114–117.

    Article  CAS  Google Scholar 

  8. Ascherio A, Munger KL, Simon KC. Vitamin Dand multiple sclerosis. Lancet Neurol 2010; 9:599–612.

    Article  Google Scholar 

  9. Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001; 358:1500–1503.

    Article  CAS  Google Scholar 

  10. Gatenby PA, Lucas RM, Engelsen O, Ponsonby AL, Clements M. Antineutrophil cytoplasmic antibody-associated vasculitides: could geographic patterns be explained by ambient ultraviolet radiation?. Arthritis Rheum 2009; 61:1417–1424.

    Article  CAS  Google Scholar 

  11. Hamzaoui K, Karray E, Sassi FH, Hamzaoui A. Vitamin D modulates peripheral immunity in patients with Behçet’s disease. Clin Exp Rheumatol 2010; 28(Suppl 60):S50–S57.

    PubMed  Google Scholar 

  12. Adorini A, Penna G. Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 2008; 4:404–412.

    Article  CAS  Google Scholar 

  13. Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 2007; 179:1634–1647.

    Article  CAS  Google Scholar 

  14. Bhalla AK, Amento EP, Serog B, Glimcher LH. 1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation. J Immunol 1984; 133:1748–1754.

    CAS  PubMed  Google Scholar 

  15. Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O’Garra A. 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 2001; 167:4974–4980.

    Article  CAS  Google Scholar 

  16. Tang J, Zhou R, Luger D, Zhu W, Silver PB, Grajewski RS, et al. Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response. J Immunol 2009; 182:4624–4632.

    Article  CAS  Google Scholar 

  17. Penna G, Roncari A, Amuchastequi S, Daniel KC, Berti E, Colonna M, et al. Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T-cells by 1, 25-dihydroxyvitamin D3. Blood 2005; 106:3490–3497.

    Article  CAS  Google Scholar 

  18. Almerighi C, Sinistro A, Cavazza A, Ciaprini C, Rocchi G, Bergamini A. 1Alpha, 25-dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in human monocytes. Cytokine 2009; 45:190–197.

    Article  CAS  Google Scholar 

  19. Szeles L, Kereszetes G, Torocsik D, Balajthy Z, Krenacs L, Poliska S, et al. 1,25-dihydroxyvitamin D3 is an autonomous regulator of the transcriptional changes leading to a tolerogenic dendritic cell phenotype. J Immunol 2009; 182:2074–2083.

    Article  CAS  Google Scholar 

  20. Hamzaoui K, Hamzaoui A. Vitamin D level and potential impact on immune cells in Behçet’s disease. OA Inflamm 2013; 1:6.

    Article  Google Scholar 

  21. Maruotti N, Cantatore FP. Vitamin D and the immune system. J Rheumatol 2010; 37:491–495.

    Article  CAS  Google Scholar 

  22. Kahan A, Hamzaoui K, Ayed K. Abnormalities of T lymphocyte subsets in Behçet’s disease demonstrated with anti-CD45RA and anti-CD29 monoclonal antibodies. J Rheumatol 1992; 19:742–746.

    CAS  PubMed  Google Scholar 

  23. Van Etten E, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol 2005; 97:93–101.

    Article  Google Scholar 

  24. Do JE, Kwon SY, Park S, Lee ES. Effects of vitamin D on expression of Tolllike receptors of monocytes from patients with Behçet’s disease. Rheumatology (Oxford) 2008; 47:840–848.

    Article  CAS  Google Scholar 

  25. Direskeneli H, Saruhan-Direskeneli G. The role of heat shock proteins in Behçet’s disease. Clin Exp Rheumatol 2003; 21:S44–S48.

    CAS  PubMed  Google Scholar 

  26. Faezi ST, Ansari N, Paragomi P, Akhlaghi M, Ghanavat M, Davatchi F. Vitamin D deficiency in patients with Behçet’s disease. J Diabetes Metab Disord 2014; 13:18.

    Article  Google Scholar 

  27. International Study Group for Behçet Disease. Criteria for diagnosis of Behçet’s disease. Lancet 1990; 335:1078–1080.

    Google Scholar 

  28. University of Leeds. Behçet’s Disease Current Activity Form 2006. Available at: medhealth.leeds.ac.uk/download/910/behcetsdiseaseactivityform. [Last accessed 2013 Jan].

  29. Krause I, Uziel Y, Guedj D, Mukamel M, Harel L, Molad Y, et al. Childhood Behçet’s disease: clinical features and comparison with adult-onset disease. Rheumatology 1999; 38:457–462.

    Article  CAS  Google Scholar 

  30. Adorini L. Selective immunointervention in autoimmune diseases: lessons from multiple sclerosis. J Chemother 2001; 13:219–234.

    Article  CAS  Google Scholar 

  31. Adorini L. Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases. Int Immunopharmacol 2002; 2:1017–1028.

    Article  CAS  Google Scholar 

  32. Schoindre Y, Terrier B, Kahn JE, Saadoun D, Souberbielle JC, Benveniste O, et al. Vitamin D and autoimmunity. Second part: Clinical aspects. Rev Med Interne 2012; 33:87–93.

    CAS  PubMed  Google Scholar 

  33. Alpsoy E, Donmez L, Onder M, Gunasti S, Usta A, Karincaoglu Y, et al. Clinical features and natural course of Behçet’s disease in 661 cases: a multicentre study. Br J Dermatol 2007; 157:901–906.

    Article  CAS  Google Scholar 

  34. Ganeb SS, Sabry HH, El-Assal MM, Kamal HM, Fayed AA. Vitamin D levels in patients with Behçet’s disease: significance and impact on disease measures. Egypt Rheumatol 2013; 35:151–157.

    Article  Google Scholar 

  35. Jassim NA, Alrasool NHA, Gorial FL. Serum vitamin D level in Behçet’s disease: single center study from Iraq. Am J Med Sci Med 2016; 4:8–10.

    Google Scholar 

  36. Karatay S, Yildirim K, Karakuzu A, Kiziltunc A, Engin RI, Eren YB, et al. Vitamin D status in patients with Behçet’s disease. Clinics 2011; 66:721–723.

    PubMed  PubMed Central  Google Scholar 

  37. Ginde AA, Liu MC, Camargo CA. Demographic differences and trends of vitamin D insufficiency in the US population 1988–2004. Arch Intern Med 2009; 169:626–632.

    Article  CAS  Google Scholar 

  38. Hirani V, Tull K, Ali A, Mindell J. Urgent action needed to improve vitamin D status among older people in England. Age Ageing 2010; 39:62–68.

    Article  Google Scholar 

  39. Lerner A, Shapira Y, Agmon-Levin N, Pacht A, Ben-Ami Shor D, López HM, et al. The clinical significance of 25OH-vitamin D status in celiac disease. Clin Rev Allergy Immunol 2012; 42:322–330.

    Article  CAS  Google Scholar 

  40. Yu S, Cantorna MT. The vitamin D receptor is required for iNKT cell development. Proc Natl Acad Sci USA 2008; 105:5207–5212.

    Article  CAS  Google Scholar 

  41. Khabbazi A, Rashtchizadeh N, Ghorbanihaghjo A, Hajialiloo M, Ghojazadeh M, Taei R, et al. The status of serum vitamin D in patients with active Behçet’s disease compared with controls. Int J Rheum Dis 2013; 17:430–434.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Rheumatology and Rehabilitation 8, Ibrahim Khattab Street, Hadaek Al Ahram, Giza, 12511, Egypt

    Manal M. Sedky Abdou & Dina A. Effat MD

  2. Department of Chemical and Clinical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt

    Marwa M. Sheta

  3. Department of Rheumatology and Rehabilitation, Shobra Hospital, Ministry of Health, Cairo, Egypt

    Amany Elsayed Haikal

Authors
  1. Manal M. Sedky Abdou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marwa M. Sheta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dina A. Effat MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Amany Elsayed Haikal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dina A. Effat MD.

Additional information

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work noncommercially, as long as the author is credited and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sedky Abdou, M.M., Sheta, M.M., Effat, D.A. et al. Assessment of 25-hydroxyvitamin D level in patients with Behçet’s Disease and its correlation with disease activity and severity. Egypt Rheumatol Rehabil 44, 30–38 (2017). https://doi.org/10.4103/1110-161X.198429

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/1110-161X.198429

Keywords